- Home
- FHTX vs THFF Comparison
FHTX vs THFF Comparison
Compare FHTX & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- THFF
- Stock Information
- Founded
- FHTX 2015
- THFF 1984
- Country
- FHTX United States
- THFF United States
- Employees
- FHTX N/A
- THFF N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- THFF Major Banks
- Sector
- FHTX Health Care
- THFF Finance
- Exchange
- FHTX Nasdaq
- THFF Nasdaq
- Market Cap
- FHTX 513.7M
- THFF 497.4M
- IPO Year
- FHTX 2020
- THFF N/A
- Fundamental
- Price
- FHTX $9.04
- THFF $48.34
- Analyst Decision
- FHTX Strong Buy
- THFF Hold
- Analyst Count
- FHTX 5
- THFF 1
- Target Price
- FHTX $16.00
- THFF $45.00
- AVG Volume (30 Days)
- FHTX 123.1K
- THFF 54.7K
- Earning Date
- FHTX 11-04-2024
- THFF 10-22-2024
- Dividend Yield
- FHTX N/A
- THFF 3.58%
- EPS Growth
- FHTX N/A
- THFF N/A
- EPS
- FHTX N/A
- THFF 3.68
- Revenue
- FHTX $25,515,000.00
- THFF $195,619,000.00
- Revenue This Year
- FHTX N/A
- THFF N/A
- Revenue Next Year
- FHTX $15.40
- THFF $12.01
- P/E Ratio
- FHTX N/A
- THFF $13.64
- Revenue Growth
- FHTX N/A
- THFF N/A
- 52 Week Low
- FHTX $2.70
- THFF $34.58
- 52 Week High
- FHTX $10.25
- THFF $50.63
- Technical
- Relative Strength Index (RSI)
- FHTX 61.38
- THFF 65.86
- Support Level
- FHTX $7.95
- THFF $42.18
- Resistance Level
- FHTX $9.54
- THFF $50.63
- Average True Range (ATR)
- FHTX 0.56
- THFF 1.33
- MACD
- FHTX 0.19
- THFF 0.61
- Stochastic Oscillator
- FHTX 82.08
- THFF 72.82
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.